Hudečková et al., 2021 - Google Patents
Gene mutations in circulating tumour DNA as a diagnostic and prognostic marker in head and neck cancer—A systematic reviewHudečková et al., 2021
View HTML- Document ID
- 11020156828033273653
- Author
- Hudečková M
- Koucký V
- Rottenberg J
- Gál B
- Publication year
- Publication venue
- Biomedicines
External Links
Snippet
(1) Background: Head and Neck Squamous Cell Carcinoma (HNSCC) is one of the most common malignancies globally. An early diagnosis of this disease is crucial, and the detection of gene mutations in circulating tumour DNA (ctDNA) through a liquid biopsy is a …
- 229920003013 deoxyribonucleic acid 0 title abstract description 56
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luchini et al. | Liquid biopsy as surrogate for tissue for molecular profiling in pancreatic cancer: A meta-analysis towards precision medicine | |
| Jeantet et al. | High intra-and inter-tumoral heterogeneity of RAS mutations in colorectal cancer | |
| Martin-Deleon et al. | EBUS-TBNA cytological samples for comprehensive molecular testing in non–small cell lung cancer | |
| Cappelletti et al. | Analysis of single circulating tumor cells in renal cell carcinoma reveals phenotypic heterogeneity and genomic alterations related to progression | |
| Hudečková et al. | Gene mutations in circulating tumour DNA as a diagnostic and prognostic marker in head and neck cancer—A systematic review | |
| Cabel et al. | Limited sensitivity of circulating tumor DNA detection by droplet digital PCR in non-metastatic operable gastric cancer patients | |
| Tsou et al. | A CRISPR test for rapidly and sensitively detecting circulating EGFR mutations | |
| Prelaj et al. | Machine learning using real-world and translational data to improve treatment selection for NSCLC patients treated with immunotherapy | |
| Franceschi et al. | IDH1 non-canonical mutations and survival in patients with glioma | |
| Sayal et al. | Salivary-based cell-free mitochondrial DNA level is an independent prognostic biomarker for patients with head and neck squamous cell carcinoma | |
| Weyerer et al. | TERT promoter mutation analysis of whole-organ mapping bladder cancers | |
| Song et al. | Genomic and transcriptomic characteristics according to size of papillary thyroid microcarcinoma | |
| Errazquin et al. | Early diagnosis of oral cancer and lesions in Fanconi anemia patients: a prospective and longitudinal study using saliva and plasma | |
| Verzè et al. | Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: a pilot study and a review of the literature | |
| Zulato et al. | Implementation of next generation sequencing-based liquid biopsy for clinical molecular diagnostics in non-small cell lung cancer (NSCLC) patients | |
| Mendoza-Moreno et al. | Prognostic factors of survival in patients with peritoneal metastasis from colorectal cancer | |
| Noskova et al. | Assessment of tumor mutational burden in pediatric tumors by real-life whole-exome sequencing and in silico simulation of targeted gene panels: how the choice of method could affect the clinical decision? | |
| Pchejetski et al. | Circulating chromosome conformation signatures significantly enhance PSA positive predicting value and overall accuracy for prostate cancer detection | |
| Hîțu et al. | Total tumor diameter and unilateral multifocality as independent predictor factors for metastatic papillary thyroid microcarcinoma | |
| Rodrigo et al. | Thermal Liquid Biopsy (TLB): A predictive score derived from serum thermograms as a clinical tool for screening lung cancer patients | |
| Bonnet et al. | Alterations in homologous recombination-related genes and distinct platinum response in metastatic triple-negative breast cancers: a subgroup analysis of the ProfiLER-01 trial | |
| Reichert et al. | Multigene profiling of circulating tumor cells (CTCs) for prognostic assessment in treatment-naïve metastatic hormone-sensitive prostate cancer (mHSPC) | |
| Salciccia et al. | Comparative prospective and longitudinal analysis on the platelet-to-lymphocyte, neutrophil-to-lymphocyte, and albumin-to-globulin ratio in patients with non-metastatic and metastatic prostate cancer | |
| Schrader et al. | Genetic stability of driver alterations in primary cutaneous diffuse large B-cell lymphoma, leg type and their relapses: a rationale for the use of molecular-based methods for more effective disease monitoring | |
| Kim et al. | Favorable conditions for the detection of EGFR T790M mutation using plasma sample in patients with non-small-cell lung cancer |